These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35807252)

  • 1. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.
    Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
    Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
    Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of ketoprofen dissolution rate by the liquisolid technique: optimization and in vitro and in vivo investigations.
    Devi S; Kumar S; Verma V; Kaushik D; Verma R; Bhatia M
    Drug Deliv Transl Res; 2022 Nov; 12(11):2693-2707. PubMed ID: 35178670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
    Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique.
    Venkateswarlu K; Preethi JK; Chandrasekhar KB
    Adv Pharm Bull; 2016 Sep; 6(3):385-390. PubMed ID: 27766222
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
    Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suitability of various excipients as carrier and coating materials for liquisolid compacts.
    Hentzschel CM; Sakmann A; Leopold CS
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1200-7. PubMed ID: 21449826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
    Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
    Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
    Khanfar M; Sheikh Salem M; Hawari R
    Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.
    Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
    Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.
    Patel DS; Pipaliya RM; Surti N
    Indian J Pharm Sci; 2015; 77(3):290-8. PubMed ID: 26180274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of liquisolid compacts for improved dissolution of telmisartan.
    Chella N; Narra N; Rama Rao T
    J Drug Deliv; 2014; 2014():692793. PubMed ID: 25371826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and characterization of ketoprofen liquisolid compacts by Box-Behnken design.
    Vittal GV; Deveswaran R; Bharath S; Basavaraj B; Madhavan V
    Int J Pharm Investig; 2012 Jul; 2(3):150-6. PubMed ID: 23373006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of dissolution rate of indomethacin: using liquisolid compacts.
    Saeedi M; Akbari J; Morteza-Semnani K; Enayati-Fard R; Sar-Reshteh-Dar S; Soleymani A
    Iran J Pharm Res; 2011; 10(1):25-34. PubMed ID: 24363677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquisolid systems to improve the dissolution of furosemide.
    Akinlade B; Elkordy AA; Essa EA; Elhagar S
    Sci Pharm; 2010; 78(2):325-44. PubMed ID: 21179350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
    Kamble PR; Shaikh KS; Chaudhari PD
    Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of liquisolid compacts of diclofenac sodium.
    Kulkarni AS; Gaja JB
    PDA J Pharm Sci Technol; 2010; 64(3):222-32. PubMed ID: 21502022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.